JP2024099528A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024099528A5 JP2024099528A5 JP2024055696A JP2024055696A JP2024099528A5 JP 2024099528 A5 JP2024099528 A5 JP 2024099528A5 JP 2024055696 A JP2024055696 A JP 2024055696A JP 2024055696 A JP2024055696 A JP 2024055696A JP 2024099528 A5 JP2024099528 A5 JP 2024099528A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- pharma
- acceptable salt
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20207719 | 2020-11-16 | ||
| EP20207719.4 | 2020-11-16 | ||
| JP2022562298A JP7465368B2 (ja) | 2020-11-16 | 2021-11-12 | 血小板活性化因子受容体アンタゴニストとしてのシクロペンタチオフェンカルボキサミド誘導体 |
| PCT/EP2021/081459 WO2022101377A1 (en) | 2020-11-16 | 2021-11-12 | Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562298A Division JP7465368B2 (ja) | 2020-11-16 | 2021-11-12 | 血小板活性化因子受容体アンタゴニストとしてのシクロペンタチオフェンカルボキサミド誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024099528A JP2024099528A (ja) | 2024-07-25 |
| JP2024099528A5 true JP2024099528A5 (https=) | 2024-11-14 |
| JP7810743B2 JP7810743B2 (ja) | 2026-02-03 |
Family
ID=73543025
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562298A Active JP7465368B2 (ja) | 2020-11-16 | 2021-11-12 | 血小板活性化因子受容体アンタゴニストとしてのシクロペンタチオフェンカルボキサミド誘導体 |
| JP2024055696A Active JP7810743B2 (ja) | 2020-11-16 | 2024-03-29 | 血小板活性化因子受容体アンタゴニストとしてのシクロペンタチオフェンカルボキサミド誘導体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562298A Active JP7465368B2 (ja) | 2020-11-16 | 2021-11-12 | 血小板活性化因子受容体アンタゴニストとしてのシクロペンタチオフェンカルボキサミド誘導体 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11766443B2 (https=) |
| EP (1) | EP4244229A1 (https=) |
| JP (2) | JP7465368B2 (https=) |
| KR (1) | KR20230109692A (https=) |
| CN (2) | CN116745300A (https=) |
| AR (1) | AR124070A1 (https=) |
| AU (1) | AU2021379248A1 (https=) |
| CA (1) | CA3200710A1 (https=) |
| CL (2) | CL2023001361A1 (https=) |
| CO (1) | CO2023005894A2 (https=) |
| CR (1) | CR20230211A (https=) |
| DO (1) | DOP2023000090A (https=) |
| EC (1) | ECSP23036210A (https=) |
| IL (1) | IL302769A (https=) |
| JO (1) | JOP20230107A1 (https=) |
| MX (1) | MX2023005678A (https=) |
| PE (1) | PE20231855A1 (https=) |
| SA (1) | SA523440809B1 (https=) |
| WO (1) | WO2022101377A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119842821A (zh) * | 2025-01-06 | 2025-04-18 | 华中科技大学 | 稳定表达血小板活化因子受体的细胞株、构建方法及应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3502392A1 (de) | 1985-01-25 | 1986-07-31 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen |
| IE870123L (en) * | 1986-01-21 | 1987-07-21 | Boehringer Ingelheim Int | Thieno-1,4-diazepines |
| PH30676A (en) | 1986-07-22 | 1997-09-16 | Boehringer Ingelhein Kg | Hetrazepine compounds which have useful pharmaceutical utility |
| US4959361A (en) * | 1987-12-18 | 1990-09-25 | Hoffmann-La Roche Inc. | Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists |
| MC1999A1 (fr) * | 1987-12-18 | 1990-01-26 | Hoffmann La Roche | Composes tricycliques |
| DE3909012A1 (de) | 1989-03-18 | 1990-09-20 | Boehringer Ingelheim Kg | Verbessertes verfahren zur herstellung von enantiomerenreinen hetrazepinen |
| DE4010528A1 (de) | 1990-04-02 | 1991-10-17 | Boehringer Ingelheim Kg | Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine |
| DE4132763A1 (de) | 1991-10-02 | 1993-04-08 | Boehringer Ingelheim Kg | Verbessertes verfahren zur herstellung von enantiomerenreinen saeureamiden hetrazepinoider struktur |
| FR2779652B1 (fr) | 1998-06-15 | 2001-06-08 | Sod Conseils Rech Applic | Utilisation de diazepines pour la preparation de medicaments destines a traiter les etats pathologiques ou les maladies dans lesquels un des recepteurs de la somatostatine est implique |
| US20050032713A1 (en) * | 2002-03-27 | 2005-02-10 | Wurtman Richard J. | Platelet-activating factor antagonists as analgesic, anti-inflammatory, uterine contraction inhibiting, and anti-tumor agents |
| CA2670031A1 (en) | 2006-11-20 | 2008-05-29 | Alantos Pharmaceuticals Holding, Inc. | Heterobicyclic metalloprotease inhibitors |
-
2021
- 2021-11-12 PE PE2023001605A patent/PE20231855A1/es unknown
- 2021-11-12 IL IL302769A patent/IL302769A/en unknown
- 2021-11-12 MX MX2023005678A patent/MX2023005678A/es unknown
- 2021-11-12 CN CN202180076849.5A patent/CN116745300A/zh active Pending
- 2021-11-12 AU AU2021379248A patent/AU2021379248A1/en active Pending
- 2021-11-12 CR CR20230211A patent/CR20230211A/es unknown
- 2021-11-12 EP EP21806745.2A patent/EP4244229A1/en active Pending
- 2021-11-12 KR KR1020237020295A patent/KR20230109692A/ko active Pending
- 2021-11-12 JP JP2022562298A patent/JP7465368B2/ja active Active
- 2021-11-12 CN CN202311341729.0A patent/CN117624188A/zh active Pending
- 2021-11-12 CA CA3200710A patent/CA3200710A1/en active Pending
- 2021-11-12 US US17/524,759 patent/US11766443B2/en active Active
- 2021-11-12 WO PCT/EP2021/081459 patent/WO2022101377A1/en not_active Ceased
- 2021-11-15 AR ARP210103159A patent/AR124070A1/es unknown
-
2023
- 2023-05-08 CO CONC2023/0005894A patent/CO2023005894A2/es unknown
- 2023-05-11 CL CL2023001361A patent/CL2023001361A1/es unknown
- 2023-05-11 DO DO2023000090A patent/DOP2023000090A/es unknown
- 2023-05-16 SA SA523440809A patent/SA523440809B1/ar unknown
- 2023-05-16 JO JOJO/P/2023/0107A patent/JOP20230107A1/ar unknown
- 2023-05-17 EC ECSENADI202336210A patent/ECSP23036210A/es unknown
- 2023-07-14 US US18/221,936 patent/US20230355638A1/en active Pending
-
2024
- 2024-02-01 CL CL2024000317A patent/CL2024000317A1/es unknown
- 2024-03-29 JP JP2024055696A patent/JP7810743B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4888347A (en) | Use of specific N-methyl-D-aspartate receptor antagonists in the prevention and treatment of neurodegeneration | |
| US5124147A (en) | Method for the treatment of endotoxic shock in a mammal | |
| JP2018535963A5 (https=) | ||
| RU2006112427A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| RU2000131183A (ru) | Производные оксииминоалкановой кислоты | |
| RU2005113168A (ru) | Производные 2-пиридона в качестве ингибитора нейтрофильной эластазы | |
| JP2021514373A5 (https=) | ||
| EP1135370A2 (en) | Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds | |
| JP2024099528A5 (https=) | ||
| EP0614363A1 (en) | Quinolone derivatives | |
| MX2010009228A (es) | Compuestos biciclicos que contienen nitrogeno que actuan en estados de dolor cronico. | |
| JPS63503139A (ja) | 高血圧疾患治療剤としてのキノリニルエ−テル又はチオエ−テルテトラゾ−ル類 | |
| JP7204780B2 (ja) | 老化細胞によって引き起こされるかまたは媒介される状態の臨床管理における使用のためおよびがんを治療するための、Ｂｃｌファミリーアンタゴニストであるアシルホスホノアミダートおよびアシルベンジルアミン | |
| SK284371B6 (sk) | Použitie oftalmologickej kompozície obsahujúcej účinné množstvo lokálneho inhibítora anhydrázy kyseliny uhličitej na prípravu liečiva | |
| JPH07215872A (ja) | ベンゾ［ｇ］キノリン類の新規使用 | |
| WO2018020357A1 (en) | Indoline derivatives | |
| US5041450A (en) | Treatment of ocular inflammation | |
| JPH0555511B2 (https=) | ||
| KR20070051768A (ko) | 레티노이드를 사용한 광수용체 변성의 방지 및/또는 감소 | |
| DE3820420A1 (de) | 6-substituierte penemester als entzuendungshemmende und antidegenerative agenzien, mittel, die diese enthalten und deren verwendung | |
| JPWO2023052363A5 (https=) | ||
| FR2763847A1 (fr) | Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1 | |
| JPS604170A (ja) | キノロン誘導体 | |
| JP6520019B2 (ja) | 新規スチルベン誘導体 | |
| JPWO2021064677A5 (https=) |